GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
L

Little Green Pharma LGP.AX · AUD

Health Care · ASX · 🇦🇺 Australia

Compare

0.06

-1.72%

Close of 9 Nov 2026, in AUD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in AUD, from our data supplier.

FY2026

Revenue

A$42.4m

FY2017FY2026

Net income

−A$1.4m

FY2017FY2026

Free cash flow

−A$790,000

FY2017FY2026

Shareholders' equity

A$83.0m

FY2017FY2026

Income statement

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
RevenueA$42.4mA$36.8mA$25.6mA$19.9mA$14.0mA$7.0mA$2.2mA$248,500A$54,447A$258
Research and developmentA$46,000A$290,000A$6.3mA$6.6mA$7.2mA$1.8mA$1.0mA$372,792A$376,358A$23,797
Operating income−A$2.0m−A$4.4m−A$7.7m−A$14.5m−A$28.4mA$24.7m−A$9.0m−A$4.7m−A$2.4m−A$217,170
Net income−A$1.4mA$3.3m−A$8.2m−A$9.2m−A$24.1m−A$4.4m−A$8.3m−A$5.5m−A$3.8m−A$217,154
Diluted earnings per share-0.000.01-0.03-0.03-0.09-0.02-0.05-0.04-0.03-0.00

Balance sheet

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Total assetsA$93.8mA$96.1mA$86.3mA$98.6mA$95.9mA$111.0mA$16.4mA$15.6mA$4.0mA$968,727
Cash and short-term investmentsA$1.4mA$2.4mA$5.0mA$12.4mA$20.1mA$40.3mA$4.3mA$9.3mA$1.5mA$726,770
Total liabilitiesA$10.7mA$11.1mA$10.2mA$16.4mA$20.5mA$17.1mA$4.1mA$1.5mA$382,282A$202,118
DebtA$4.7mA$4.7mA$5.1mA$11.9mA$15.9mA$1.4mA$1.7mA$1.3m—A$56,373
Shareholders' equityA$83.0mA$85.0mA$77.3mA$82.2mA$75.5mA$93.9mA$12.3mA$14.1mA$3.6mA$766,609
Shares outstanding306m304m303m299m259m235m153m133m133m306m

Cash flow

Fiscal years

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017
Cash from operationsA$38,999−A$917,000A$67,000−A$6.9m−A$17.2m−A$5.1m−A$6.0m−A$3.3m−A$1.6m−A$25,241
Capital spending−A$828,999−A$237,000−A$716,000−A$4.9m−A$7.7m−A$1.1m−A$6.8m−A$473,866−A$298,949−A$89,615
Free cash flow−A$790,000−A$1.2m−A$649,000−A$11.9m−A$24.8m−A$6.2m−A$12.9m−A$3.8m−A$1.9m−A$114,856
Dividends paid—−A$3.9m−A$2.5m−A$5.8m—−A$1.0m−A$8.5m———

Latest quarters

By quarter end

Mar 2026Sept 2025Mar 2025Dec 2024Sept 2024Mar 2024Sept 2023Jun 2023
RevenueA$23.2mA$19.2mA$19.3mA$9.7mA$17.5mA$13.1mA$12.5mA$6.3m
Operating income−A$584,000−A$1.4m−A$701,000A$294,000−A$3.3m−A$6.2m−A$4.6m−A$905,192
Net income−A$482,000−A$926,000A$6.8mA$3.4m−A$3.5m−A$6.0m−A$2.1m−A$1.0m
Diluted earnings per share-0.00-0.000.020.01-0.01-0.02-0.01-0.00
Cash from operations——−A$1.0m———−A$1.0m—
Capital spending—————−A$1.0m——
Total assetsA$93.8mA$97.6mA$96.1mA$96.1mA$83.0mA$86.4mA$92.9mA$92.9m
Cash and short-term investmentsA$1.4mA$2.3mA$2.4mA$2.4mA$4.8mA$5.0mA$6.2mA$6.2m
DebtA$3.5mA$4.9mA$4.7mA$2.5mA$2.4mA$4.4mA$2.7mA$2.6m
Shareholders' equityA$83.0mA$86.0mA$85.0mA$85.0mA$72.6mA$77.3mA$80.7mA$80.7m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue28.8%43.4%—
Operating income-48.6%——
Net income-46.5%-20.2%—

Valuation history

At each fiscal year end

FY2026FY2025FY2024FY2023FY2022FY2021FY2020
Price to earnings-12.611.4-4.7-4.4-1.9-32.1-10.6
Price to sales0.41.01.52.03.320.039.6

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.